Navigation Links
Acceleron awarded $1.5 million grant from Muscular Dystrophy Association to support ACE-031
Date:1/6/2011

Cambridge, Mass. Jan. 6, 2011 Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded a $1.5 million grant from the Muscular Dystrophy Association to support clinical studies of ACE-031 in Duchenne Muscular Dystrophy (DMD), a disabling neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic designed to build muscle and increase strength by blocking proteins that inhibit muscle growth and strength.

"We are honored to be recognized and supported by the Muscular Dystrophy Association as we work collectively to develop promising therapies for the treatment of patients with Duchenne Muscular Dystrophy," said John Knopf, PhD, CEO of Acceleron. "This award along with our collaboration with Shire brings together the resources of several committed groups to evaluate the therapeutic potential of ACE-031 in DMD."

"Having invested more than $164 million on DMD-related research, MDA is eager to help Acceleron advance the clinical trial work needed to determine optimal doses of ACE-031 in terms of safety and pharmacodynamic activity," said R. Rodney Howell, M.D., Chairman of the MDA Board of Directors.

The MDA grant, awarded through the Association's Venture Philanthropy Program (MVP), will support ongoing clinical studies of ACE-031 in boys with DMD. The new investment will enable Acceleron to gather safe dosing and pharmcodynamic activity information vital to future studies of ACE-031. For more information on these ongoing studies, visit clinicaltrials.gov and query study identifiers NCT01099761 and NCT01239758.

"MDA is pleased to support Acceleron's efforts in the fight against Duchenne Muscular Dystrophy," said Valerie Cwik, M.D., MDA Executive Vice President Research
'/>"/>

Contact: Jim Brown
jbrown@mdausa.org
520-529-5317
Muscular Dystrophy Association
Source:Eurekalert

Page: 1 2

Related biology news :

1. Stevens awarded $1M for advanced biofuels research
2. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
3. BIO-keys(R) Law Enforcement Group Awarded $700,000 in New Contracts
4. Broad Institute awarded major grant to bolster epigenomics research
5. LSUHSC awarded patent for compound inhibiting cancer and other diseases
6. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
7. Field-hospital-on-a-chip project awarded to nanoengineer from UC San Diego
8. SAIC Awarded $37 Million Contract to Support U.S. Army Program Executive Office - Enterprise Information Systems
9. Eastman Dental Center awarded $1.6 million to find ways to prevent cavities
10. Scripps Florida scientists awarded $1.5M to fight major water and food parasites
11. BIO-key(R) Awarded PocketCop(R) Contracts From Major Law Enforcement Agencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 14, 2014, by lightning from a weather system that moved ... fires: Stokes Fire, Gold Hikes Fire, French Creek Fire and ... now one larger fire. The fires are burning in timber ... acres in size. The present fire situation continues to ... firefighter safety is the priority on the Carlton Complex fires. ...
(Date:7/22/2014)... for Health Policy and Economics have linked tighter ... rates for schizophrenic individuals. , The study comes ... health actually save money, when other costs are ... an extra approval step before tests or treatments ... called prior authorization is intended to encourage ...
(Date:7/22/2014)... research team from the National Institute of Standards ... has demonstrated a dramatically improved technique for analyzing ... vibration "signatures." The new NIST technique is an ... spectroscopy, but one that delivers signals that are ... scattering, and 100 times stronger than obtained from ...
Breaking Biology News(10 mins):Are state Medicaid policies sentencing people with mental illnesses to prison? 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 3
... (RFRH) systems with mulches were first researched in the ... water availability and to increase crop production. In RFRH ... bare or mulched furrows serve as planting zones. The ... in many parts of the world as a means ...
... of 34 institutions in 15 countries contributing to the measurements ... network, InGOS. , The network focuses on providing accurate information ... for a more vigorous climate action. In order to ... of greenhouse gas emissions is essential and not only ...
... article in the New England Journal of Medicine ... B was able to convert severe hemophilia to moderate or ... Methods Editor for Human Gene Therapy and ... represents an important milestone and "demonstrates unequivocally that gene therapy ...
Cached Biology News:Improved rainwater harvesting system promising 2DTU is participating in a European network on measurement of greenhouse gases 2Commentary and podcast on landmark gene therapy clinical trial for hemophilia B 2
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and distributor ... other markets, announced today that it has closed on ... investors led by Novit L.P., an investment arm of ... the signing of a Securities Purchase Agreement under which ... a price per share of $1.00, resulting in a ...
(Date:7/22/2014)... Parsippany, NJ (PRWEB) July 22, 2014 ... analytical, precision, portable, and mechanical balances and scales, ... precision balances has won Laboratory Equipment magazine’s 2014 ... is the second consecutive year the Explorer was ... readers. The annual Readers’ Choice Awards celebrates “excellence ...
(Date:7/22/2014)... and SHENZHEN, China , July ... LTD, (BGI Tech), a subsidiary of BGI, the ... launch of a new human whole exome sequencing ... newly offered service includes in-depth bioinformatics analysis and ... until December 31, 2014. Complete ...
(Date:7/22/2014)... Quorum Review IRB, the industry leader in central IRB ... Quick Step™ . The offering went live on July ... need for seamless study start-up with a large volume of ... 50 or more North American investigator sites, as well as ... of 80 or more. Qualifying studies may also enroll international ...
Breaking Biology Technology:CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3
... EUREKA Cluster dedicated to Smart Systems Integration, will be ... community on 14-17 June 2011 in Helsinki, Finland. The ... the creation of new consortia and new projects by ... discuss proposals. EURIPIDES, in close cooperation with VTT and ...
... 20, 2011 Harvest Technologies Corp. ( www.harvesttech.com ) ... sixty patient Heart Failure trial have been enrolled at ... trial is intended to evaluate the safety and clinical ... patients with Congestive Heart Failure (CHF) when using a ...
... full year as a public company, 2010, the biotechnology developer Divine ... and grew Q4 revenue by 88 percent over the previous Q4, ... $5.4 million, up by $1.9 million over the previous year. Fourth-quarter ... quarter of 2009. The maker of topical treatments for ...
Cached Biology Technology:Harvest Technologies Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE) 2Divine Skin Posts Record Sales for 2010: Up 55% Over 2009 2Divine Skin Posts Record Sales for 2010: Up 55% Over 2009 3